RBC
ALXN

Roble Belko & Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Roble Belko & Company’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-61
Closed -$7K – 359
2017
Q1 		$7K Hold
61
– – ﹤0.01% 243
2016
Q4 		$7K Buy
+61
New +$7K ﹤0.01% 254